DK0821588T3 - Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder - Google Patents

Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder

Info

Publication number: DK0821588T3
Authority: DK; Denmark
Prior art keywords: levobupivacaine; pregnant women; anesthetic; anaesthetic; formulated
Prior art date: 1995-04-13

Application number

DK96910087T

Other languages

Danish (da)

English (en)

Inventor

Hazel Judith Bardsley

Robert William Gristwood

Original Assignee

Darwin Discovery Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-13

Filing date

1996-04-15

Publication date

2003-07-28

1995-04-13 Priority claimed from GBGB9507677.4A external-priority patent/GB9507677D0/en

1995-10-27 Priority claimed from US08/549,408 external-priority patent/US5849763A/en

1996-04-15 Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd

2003-07-28 Application granted granted Critical

2003-07-28 Publication of DK0821588T3 publication Critical patent/DK0821588T3/da

Links

230000003444 anaesthetic effect Effects 0.000 title abstract 2
LEBVLXFERQHONN-INIZCTEOSA-N levobupivacaine Chemical compound CCCCN1CCCC[C@H]1C(=O)NC1=C(C)C=CC=C1C LEBVLXFERQHONN-INIZCTEOSA-N 0.000 title abstract 2
229960004288 levobupivacaine Drugs 0.000 title abstract 2

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics

Landscapes

Health & Medical Sciences (AREA)
Anesthesiology (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicinal Preparation (AREA)

DK96910087T 1995-04-13 1996-04-15 Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder DK0821588T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
GBGB9507677.4A GB9507677D0 (en)	1995-04-13	1995-04-13	Pharmaceutical formulation and dose
US08/549,408 US5849763A (en)	1993-10-13	1995-10-27	Use of levobupivacaine as an anesthetic agent
PCT/GB1996/000912 WO1996032109A2 (fr)	1995-04-13	1996-04-15	Levobupivacaine et son utilisation comme anesthesique chez la femme enceinte

Publications (1)

Publication Number	Publication Date
DK0821588T3 true DK0821588T3 (da)	2003-07-28

Family

ID=26306876

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96910087T DK0821588T3 (da)	1995-04-13	1996-04-15	Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder

Country Status (15)

Country	Link
EP (1)	EP0821588B1 (fr)
JP (1)	JPH11503444A (fr)
CN (1)	CN1145483C (fr)
AT (1)	ATE243036T1 (fr)
AU (1)	AU704806B2 (fr)
CA (1)	CA2216583C (fr)
DE (1)	DE69628743T2 (fr)
DK (1)	DK0821588T3 (fr)
ES (1)	ES2201179T3 (fr)
HU (1)	HU224226B1 (fr)
MX (1)	MX9707875A (fr)
NO (1)	NO318548B1 (fr)
PL (1)	PL184052B1 (fr)
PT (1)	PT821588E (fr)
WO (1)	WO1996032109A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5849763A (en)	1993-10-13	1998-12-15	Darwin Discovery Limited	Use of levobupivacaine as an anesthetic agent
EP0727210B1 (fr) *	1993-10-13	2001-12-19	Darwin Discovery Limited	Agent analgésique et son utilisation
GB9704349D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704352D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704351D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
WO1999004771A2 (fr) *	1997-07-21	1999-02-04	Darwin Discovery Limited	Levobupivacaine et son utilisation
US6432986B2 (en)	1997-07-21	2002-08-13	Bruce H. Levin	Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
US7799337B2 (en)	1997-07-21	2010-09-21	Levin Bruce H	Method for directed intranasal administration of a composition
WO1999004772A2 (fr) *	1997-07-22	1999-02-04	Darwin Discovery Limited	Levobupivacine et son utilisation
US10821087B2 (en)	2015-07-24	2020-11-03	Neon Laboratories Limited	Stabilized injectable emulsion of Propofol and Ketamine
WO2019226599A1 (fr) *	2018-05-22	2019-11-28	Alkalidx, Inc.	Diagnostics et traitements de sujets insensibles à un anesthésique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9321061D0 (en) *	1993-10-13	1993-12-01	Chiroscience Ltd	Analgestic agent and its use
EP0727210B1 (fr) *	1993-10-13	2001-12-19	Darwin Discovery Limited	Agent analgésique et son utilisation

1996
- 1996-04-15 AU AU53395/96A patent/AU704806B2/en not_active Expired
- 1996-04-15 CA CA002216583A patent/CA2216583C/fr not_active Expired - Lifetime
- 1996-04-15 HU HU9900507A patent/HU224226B1/hu active IP Right Grant
- 1996-04-15 JP JP8530831A patent/JPH11503444A/ja active Pending
- 1996-04-15 DE DE69628743T patent/DE69628743T2/de not_active Expired - Lifetime
- 1996-04-15 MX MX9707875A patent/MX9707875A/es unknown
- 1996-04-15 DK DK96910087T patent/DK0821588T3/da active
- 1996-04-15 PT PT96910087T patent/PT821588E/pt unknown
- 1996-04-15 AT AT96910087T patent/ATE243036T1/de active
- 1996-04-15 ES ES96910087T patent/ES2201179T3/es not_active Expired - Lifetime
- 1996-04-15 PL PL96322763A patent/PL184052B1/pl unknown
- 1996-04-15 CN CNB961939435A patent/CN1145483C/zh not_active Expired - Lifetime
- 1996-04-15 EP EP96910087A patent/EP0821588B1/fr not_active Expired - Lifetime
- 1996-04-15 WO PCT/GB1996/000912 patent/WO1996032109A2/fr not_active Ceased
1997
- 1997-10-10 NO NO19974708A patent/NO318548B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPH11503444A (ja)	1999-03-26
EP0821588B1 (fr)	2003-06-18
CA2216583A1 (fr)	1996-10-17
DE69628743D1 (de)	2003-07-24
MX9707875A (es)	1997-11-29
PL184052B1 (pl)	2002-08-30
HUP9900507A2 (hu)	1999-06-28
CA2216583C (fr)	2007-10-30
CN1145483C (zh)	2004-04-14
HUP9900507A3 (en)	1999-11-29
PT821588E (pt)	2003-11-28
WO1996032109A3 (fr)	1997-02-13
DE69628743T2 (de)	2004-05-13
NO318548B1 (no)	2005-04-11
WO1996032109A2 (fr)	1996-10-17
EP0821588A2 (fr)	1998-02-04
HU224226B1 (hu)	2005-06-28
AU704806B2 (en)	1999-05-06
PL322763A1 (en)	1998-02-16
CN1184426A (zh)	1998-06-10
HK1012847A1 (en)	1999-08-13
NO974708D0 (no)	1997-10-10
ATE243036T1 (de)	2003-07-15
NO974708L (no)	1997-12-10
ES2201179T3 (es)	2004-03-16
AU5339596A (en)	1996-10-30

Publication	Publication Date	Title
DE69531457D1 (en)	2003-09-11	Sulfonamide
NO985464L (no)	1999-01-18	Konsentrert antistoffpreparat
SE9404196D0 (sv)	1994-12-02	New antithrombotic formulation
DE69402330D1 (de)	1997-04-30	Analgetisches mittel und dessen verwendung
DE59009034D1 (de)	1995-06-08	Desodorierende kosmetische mittel.
FI962445A7 (fi)	1996-06-12	Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
EE9700081A (et)	1997-10-15	Keratinotsüüdi kasvufaktori analoogid
MX9304633A (es)	1994-02-28	Composiciones orales.
DK0424028T3 (da)	1996-01-29	S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DK0821588T3 (da)	2003-07-28	Levobupivacain og anvendelse heraf som et anæstetikum til gravide kvinder
DK1077941T3 (da)	2009-12-07	Forbindelser med væksthormonfrigörende egenskaber
DE69814851D1 (de)	2003-06-26	Verwendung von levobupivacaine in gesichtschirugie
MY103990A (en)	1993-10-30	4-aryl-piperidine (or pyrrolidine or hexahydroazepine) carbinols and heterocyclic analogs thereof.
BG100248A (bg)	1996-07-31	Инхибитори на скваленсинтетаза
ATE270113T1 (de)	2004-07-15	Zusammenstellungen zur verbesserten wundheilung
ES2196802T3 (es)	2003-12-16	Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
SE9500897D0 (sv)	1995-03-14	The pharmacological use of certain cystine derivatives
NO892188D0 (no)	1989-05-31	Fremgangsmaate og anlegg for oksygenering.
ATE293605T1 (de)	2005-05-15	Fluorierte 3,4-dihydrochinolin-derivative als nos-inhibitoren